FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

30316711000001106: Binosto 70mg effervescent tablets (Internis Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Sep 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2526601000001115 Binosto 70mg effervescent tablets (Internis Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2526621000001110 Binosto 70mg effervescent tablets (Internis Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Binosto 70mg effervescent tablets (Internis Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Binosto 70mg effervescent tablets (Internis Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Binosto 70mg effervescent tablets (Internis Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Binosto 70mg effervescent tablets (Internis Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Binosto 70mg effervescent tablets (Internis Pharmaceuticals Ltd) Is a Alendronic acid 70mg effervescent tablets sugar free true Inferred relationship Existential restriction modifier
Binosto 70mg effervescent tablets (Internis Pharmaceuticals Ltd) Has active ingredient Alendronate true Inferred relationship Existential restriction modifier
Binosto 70mg effervescent tablets (Internis Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Binosto 70mg effervescent tablets (Internis Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Binosto 70mg effervescent tablets (Internis Pharmaceuticals Ltd) Has specific active ingredient Alendronate sodium true Inferred relationship Existential restriction modifier
Binosto 70mg effervescent tablets (Internis Pharmaceuticals Ltd) Has dispensed dose form Effervescent tablet false Inferred relationship Existential restriction modifier
Binosto 70mg effervescent tablets (Internis Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Alendronic acid true Inferred relationship Existential restriction modifier
Binosto 70mg effervescent tablets (Internis Pharmaceuticals Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Binosto 70mg effervescent tablets (Internis Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Binosto 70mg effervescent tablets (Internis Pharmaceuticals Ltd) Is a Binosto true Inferred relationship Existential restriction modifier
Binosto 70mg effervescent tablets (Internis Pharmaceuticals Ltd) Has manufactured dose form Effervescent tablet false Inferred relationship Existential restriction modifier
Binosto 70mg effervescent tablets (Internis Pharmaceuticals Ltd) Has basis of strength substance Alendronic acid true Inferred relationship Existential restriction modifier
Binosto 70mg effervescent tablets (Internis Pharmaceuticals Ltd) Has dispensed dose form Conventional release effervescent oral tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Binosto 70mg effervescent tablets (Internis Pharmaceuticals Ltd) 4 tablet Has AMP True Binosto 70mg effervescent tablets (Internis Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start